AAAAAA
Results: 1051-1075/15678
Authors:
Scheibner, J
Fuchs, M
Hormann, E
Stange, EF
Citation: J. Scheibner et al., Complex feedback regulation of bile acid synthesis in the hamster: The role of newly synthesized cholesterol, HEPATOLOGY, 30(1), 1999, pp. 230-237
Authors:
Janssen, HLA
Gerken, G
Carreno, V
Marcellin, P
Naoumov, NV
Craxi, A
Ring-Larsen, H
Kitis, G
van Hattum, J
de Vries, RA
Michielsen, PP
ten Kate, FJW
Hop, WCJ
Heijtink, RA
Honkoop, P
Schalm, SW
Citation: Hla. Janssen et al., Interferon alfa for chronic hepatitis B infection: Increased efficacy of prolonged treatment, HEPATOLOGY, 30(1), 1999, pp. 238-243
Authors:
Tillmann, HL
Trautwein, C
Bock, T
Boker, KHW
Jackel, E
Glowienka, M
Oldhafer, K
Bruns, I
Gauthier, J
Condreay, LD
Raab, HR
Manns, MP
Citation: Hl. Tillmann et al., Mutational pattern of hepatitis B virus on sequential therapy with famciclovir and lamivudine in patients with hepatitis B virus reinfection occurring under HBIg immunoglobulin after liver transplantation, HEPATOLOGY, 30(1), 1999, pp. 244-256
Authors:
Di Marco, V
Lo Iacono, O
Camma, C
Vaccaro, A
Giunta, M
Martorana, G
Fuschi, P
Almasio, PL
Craxi, A
Citation: V. Di Marco et al., The long-term course of chronic hepatitis B, HEPATOLOGY, 30(1), 1999, pp. 257-264
Authors:
Sherman, KE
Rouster, SD
Mendenhall, C
Thee, D
Citation: Ke. Sherman et al., Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease, HEPATOLOGY, 30(1), 1999, pp. 265-270
Authors:
Everson, GT
Jensen, DM
Craig, JR
van Leeuwen, DJ
Bain, VG
Ehrinpreis, MN
Albert, D
Joh, T
Witt, K
Citation: Gt. Everson et al., Efficacy of interferon treatment for patients with chronic hepatitis C: Comparison of response in cirrhotics, fibrotics, or nonfibrotics, HEPATOLOGY, 30(1), 1999, pp. 271-276
Authors:
Carreno, V
Marcellin, P
Hadziyannis, S
Salmeron, J
Diago, M
Kitis, GE
Vafiadis, I
Schalm, SW
Zahm, F
Manzarbeitia, F
Jimenez, FJ
Quiroga, JA
Citation: V. Carreno et al., Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a, HEPATOLOGY, 30(1), 1999, pp. 277-282
Authors:
Matsumoto, A
Yeo, AET
Shih, JWK
Tanaka, E
Kiyosawa, K
Alter, HJ
Citation: A. Matsumoto et al., Transfusion-associated TT virus infection and its relationship to liver disease, HEPATOLOGY, 30(1), 1999, pp. 283-288
Authors:
Parana, R
Vitvitski, L
Andrade, Z
Trepo, C
Cotrim, H
Bertillon, P
Silva, F
Silva, L
de Oliveira, IR
Lyra, L
Citation: R. Parana et al., Acute sporadic non-A, non-B hepatitis in northeastern Brazil: Etiology andnatural history, HEPATOLOGY, 30(1), 1999, pp. 289-293
Authors:
Tagger, A
Donato, F
Ribero, ML
Binelli, G
Gelatti, U
Portera, G
Albertini, A
Fasola, M
Chiesa, R
Nardi, G
Citation: A. Tagger et al., A case-control study on a novel DNA virus (TT virus) infection and hepatocellular carcinoma, HEPATOLOGY, 30(1), 1999, pp. 294-299
Authors:
Yamamoto, M
Hayashi, N
Takehara, T
Ueda, K
Mita, E
Tatsumi, T
Sasaki, Y
Kasahara, A
Hori, M
Citation: M. Yamamoto et al., Intracellular single-chain antibody against hepatitis B virus core proteininhibits the replication of hepatitis B virus in cultured cells, HEPATOLOGY, 30(1), 1999, pp. 300-307
Authors:
von Weizsacker, F
Kock, J
Wieland, S
Offensperger, WB
Blum, HE
Citation: F. Von Weizsacker et al., Dominant negative mutants of the duck hepatitis B virus core protein interfere with RNA pregenome packaging and viral DNA synthesis, HEPATOLOGY, 30(1), 1999, pp. 308-315
Authors:
Beard, MR
Abell, G
Honda, M
Carroll, A
Gartland, M
Clarke, B
Suzuki, K
Lanford, R
Sangar, DV
Lemon, SM
Citation: Mr. Beard et al., An infectious molecular clone of a Japanese genotype 1b hepatitis C virus, HEPATOLOGY, 30(1), 1999, pp. 316-324
Authors:
Angulo, P
Lindor, KD
Citation: P. Angulo et Kd. Lindor, Primary sclerosing cholangitis, HEPATOLOGY, 30(1), 1999, pp. 325-332
Authors:
Tsubouchi, H
Citation: H. Tsubouchi, Hepatocyte growth factor for liver disease, HEPATOLOGY, 30(1), 1999, pp. 333-334
Authors:
Neuberger, J
Citation: J. Neuberger, Eosinophils and primary biliary cirrhosis - Stoking the fire?, HEPATOLOGY, 30(1), 1999, pp. 335-337
Authors:
Davila, R
Keeffe, EB
Citation: R. Davila et Eb. Keeffe, Prednisone withdrawal advocates: Beware of recurrent autoimmune hepatitis - Comments, HEPATOLOGY, 30(1), 1999, pp. 338-339
Authors:
Koretz, RL
Citation: Rl. Koretz, Life tables and denominators, HEPATOLOGY, 30(1), 1999, pp. 340-340
Authors:
Lin, SM
Liaw, YF
Citation: Sm. Lin et Yf. Liaw, Life tables and denominators, HEPATOLOGY, 30(1), 1999, pp. 340-341
Authors:
Ahr, HJ
Bomhard, E
Schmidt, U
Schluter, G
Citation: Hj. Ahr et al., Acarbose and acetaminophen: A dangerous combination?, HEPATOLOGY, 30(1), 1999, pp. 341-342
Authors:
Harman-Boehm, I
Zingman, L
Hilzenrat, N
Citation: I. Harman-boehm et al., No evidence for anti-islet autoimmunity in diabetes mellitus associated with chronic hepatitis C infection, HEPATOLOGY, 30(1), 1999, pp. 342-342
Authors:
O'Connor, JB
Imperiale, TF
Singer, ME
Citation: Jb. O'Connor et al., Economic models of hepatitis A virus immunization, HEPATOLOGY, 30(1), 1999, pp. 343-344
Authors:
Meltzer, M
Messonnier, ML
Citation: M. Meltzer et Ml. Messonnier, Economic models of hepatitis A virus immunization, HEPATOLOGY, 30(1), 1999, pp. 343-343
Authors:
Das, A
Citation: A. Das, Economic models of hepatitis A virus immunization - Reply, HEPATOLOGY, 30(1), 1999, pp. 344-345
Authors:
Sanyal, AJ
Koff, RS
Citation: Aj. Sanyal et Rs. Koff, Introduction: Methodologies in outcomes research-hepatology prepares for the new millennium, HEPATOLOGY, 29(6), 1999, pp. 1S-2S